ARTV Overview

U.S. Stock Market Performance: U.S. stocks experienced a decline, with the Nasdaq Composite down 0.4%, the Dow down 0.27%, and the S&P 500 falling 0.11%. Health care shares rose by 0.9%, while energy stocks dropped by 1.5%.

Equities Trading Highlights: Notable stock movements included a 47% increase for 3 E Network Technology Group after an AI data center agreement, and a 72% drop for iRobot Corp following its Chapter 11 bankruptcy filing.

Commodity Market Update: Oil prices fell by 1.5% to $56.58, while gold decreased by 0.1%. In contrast, silver rose by 2.2% and copper increased by 1.1%.

International Market Trends: European shares saw gains, with the eurozone's STOXX 600 up 0.74%, while Asian markets closed lower, including a 1.31% drop in Japan's Nikkei and a 1.34% dip in Hong Kong's Hang Seng.

U.S. Stock Market Performance: U.S. stocks showed mixed results, with the Dow Jones gaining 0.1%, while the NASDAQ fell slightly. The S&P 500 also saw a modest increase, and health care shares rose by 1%, contrasting with a 1% drop in energy stocks.

Manufacturing Index Decline: The NY Empire State Manufacturing Index fell to -3.9 in December, significantly down from a one-year high of 18.7 the previous month, and below market expectations of 10.

Notable Stock Movements: 3 E Network Technology Group's shares surged 88% after a new AI data center agreement, while iRobot Corp's shares plummeted 69% following its Chapter 11 bankruptcy filing.

Global Market Trends: European shares rose, with the eurozone's STOXX 600 gaining 0.8%, while Asian markets closed lower, with Japan's Nikkei down 1.31% and Hong Kong's Hang Seng down 1.34%.

Exicure, Inc. Surge: Exicure, Inc. saw a significant after-hours increase of 72.61% to $9.20 following positive Phase 2 trial results for its therapy in multiple myeloma patients, with 90% of participants achieving the primary endpoint.

Artiva Biotherapeutics and iBio Performance: Artiva Biotherapeutics rose 10.39% after hours despite a regular session decline, while iBio advanced 8.38% after hours, continuing its earlier gains without any new announcements.

Cartesian Therapeutics and Metagenomi Gains: Cartesian Therapeutics increased 6.55% after hours, while Metagenomi gained 7.18% after hours, with the latter planning to present preclinical data at an upcoming conference.

Wave Life Sciences and Assembly Biosciences Updates: Wave Life Sciences shares rose 4.97% after hours following a public offering announcement, and Assembly Biosciences gained 5.96% after reporting positive interim results from Phase 1b studies of its investigational HSV inhibitors.

FDA Fast Track Designation: Artiva Biotherapeutics' lead candidate AlloNK has received Fast Track Designation from the FDA for refractory rheumatoid arthritis, marking it as the first deep B-cell depleting therapy to gain this recognition, which could enhance treatment options for patients.

Investment Implications: The Fast Track designation may improve Artiva's investment narrative by attracting investor interest and positioning the company favorably in the autoimmune treatment pipeline, despite ongoing financial challenges and the need for successful clinical trials.